Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Reproducibility of multifocal visual evoked potential and traditional visual evoked potential in normal and multiple sclerosis eyes.
Relapses and disability accumulation in progressive multiple sclerosis.
Quantifying progression of multiple sclerosis via classification of depth videos.
Elevated Cerebrospinal Fluid Opening Pressure in a Pediatric Demyelinating Disease Cohort.
Drugs that Treat Skin Conditions May Help Combat Multiple Sclerosis.
Multiple sclerosis in US minority populations: Clinical practice insights.
Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.
The Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic Review.
Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Failed Concept.
Genetic analysis of the isolated Faroe Islands reveals SORCS3 as a potential multiple sclerosis risk gene.
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.
APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction.
Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson's disease.
Safety and efficacy of natalizumab in children with multiple sclerosis.
Transverse myelitis with Brown-Sèquard syndrome after H1N1 immunization.
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosis.
Differentiation of neuromyelitis optica from multiple sclerosis in a cohort from the mainland of China.
High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
Most Scottish neurologists do not apply the 2010 McDonald criteria when diagnosing multiple sclerosis.
Integrating the ICF with positive psychology: Factors predicting role participation for mothers with multiple sclerosis.
Acute paraplegia caused by Schistosoma mansoni.
Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis.
An initial validation of the Italian Mishel Uncertainty Illness Scale (MUIS) for relapsing remitting multiple sclerosis patients.
Pages
« first
‹ previous
…
427
428
429
430
431
432
433
434
435
…
next ›
last »